# PINIT Study: Primary Intranasal Insulin Trial

> **NCT03182322** · PHASE2 · COMPLETED · sponsor: **Technical University of Munich** · enrollment: 38 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** intranasal insulin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03182322
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-25
- **Primary completion:** 2021-06-07
- **Final completion:** 2021-06-07
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2021-06-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03182322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03182322, "PINIT Study: Primary Intranasal Insulin Trial". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03182322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*